梅玫 - 天津医科大学

个人简介

教育背景 1987.09-1993.06 天津师范大学学士 1998.09-2002.06 天津医科大大学硕士 2006.09-2010.07 天津大学博士工作经历 2003.11-2010.10 天津医科大学基础医学研究中心副研究员 2010.11-今天津医科大学基础医学研究中心研究员

研究领域

非编码RNA调调控肿瘤转移的分子机制

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Ren Y, Zhou X, Liu X, Jia HH, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Sun T, Jiao HX, Tian WP, Yang YQ, Zhao XL, Zhang L, Mei M*, Kang CS. Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy.Cancer Lett. 2016 Apr 28; 374(1):96-106. 2. Ren Y, Zhou X, Yang JJ, Liu X, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Tian WP, Zhang L, Mei M*, Kang CS. AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.Cancer Lett. 2015 Jul 1; 362(2):174-82. 3. Ren Y, Zhou X, Qi Y, Li G, Mei M*, Yao Z. PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway.Oncol Rep. 2012 Sep;28(3):943-8 4. Mei M, Ren Y, Zhou X, Yuan XB, Han L, Wang GX, Jia Z, Pu PY, Kang CS, Yao Z. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.Technol Cancer Res Treat. 2010 Feb;9(1):77-86. 5. Mei M, Ren Y, Zhou X, Li F, Yuan XB, Jiang LH, Kang CS, Yao Z. The suppression of breast cancer cells in vitro by PAMAM dendrimer mediated 5-Fluorouracil chemotherapy combined with antisense microRNA-21 gene therapy. Journal of Applied Polymer Science. 2009,114:3760-3766.